KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Supernus Pharmaceuticals (SUPN) Debt Ratio (2020 - 2025)

Historic Debt Ratio for Supernus Pharmaceuticals (SUPN) over the last 9 years, with Q3 2025 value amounting to 0.01.

  • Supernus Pharmaceuticals' Debt Ratio fell 7718.97% to 0.01 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01, marking a year-over-year decrease of 7718.97%. This contributed to the annual value of 0.03 for FY2024, which is 1509.15% down from last year.
  • Latest data reveals that Supernus Pharmaceuticals reported Debt Ratio of 0.01 as of Q3 2025, which was down 7718.97% from 0.02 recorded in Q1 2025.
  • In the past 5 years, Supernus Pharmaceuticals' Debt Ratio ranged from a high of 0.25 in Q4 2021 and a low of 0.01 during Q3 2025
  • Over the past 5 years, Supernus Pharmaceuticals' median Debt Ratio value was 0.03 (recorded in 2024), while the average stood at 0.06.
  • The largest annual percentage gain for Supernus Pharmaceuticals' Debt Ratio in the last 5 years was 148059.95% (2022), contrasted with its biggest fall of 9505.9% (2022).
  • Quarter analysis of 5 years shows Supernus Pharmaceuticals' Debt Ratio stood at 0.25 in 2021, then plummeted by 95.06% to 0.01 in 2022, then skyrocketed by 228.52% to 0.04 in 2023, then dropped by 15.09% to 0.03 in 2024, then crashed by 77.13% to 0.01 in 2025.
  • Its Debt Ratio was 0.01 in Q3 2025, compared to 0.02 in Q1 2025 and 0.03 in Q4 2024.